Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Hambrecht & Quist Capital Management

Latest statistics and disclosures from Tekla Capital Management's latest quarterly 13F-HR filing:

Top 5 stock holdings are AMGN, JNJ, GILD, REGN, VRTX, and represent 23.58% of Tekla Capital Management's stock portfolio.
Added to shares of these 10 stocks: MRK (+$20M), AMGN (+$14M), REGN (+$13M), PODD (+$13M), THC (+$12M), BAX (+$12M), IQV (+$10M), PCVX (+$9.5M), DHR (+$8.9M), Horizon Therapeutics (+$7.4M).
Started 9 new stock positions in HLVX, PODD, AKRO, ZNTL, Horizon Therapeutics, INSP, THC, AMLX, XNCR.
Reduced shares in these 10 stocks: LLY (-$35M), CI (-$24M), Seagen (-$22M), BMY (-$13M), UNH (-$13M), SRPT (-$12M), ISRG (-$9.8M), TVTX (-$9.4M), , ARGX (-$8.9M).
Sold out of its positions in ADUS, ALGN, AMED, ARWR, BPMC, Cardiovascular Systems, CTLT, KURA, Laboratory Corp. of America Holdings, LNTH. MRSN, OPCH, Prometheus Biosciences, SNDX, TVTX, RARE, ZLAB, BHVN, Vectivbio Hldg, MRUS.
Tekla Capital Management was a net seller of stock by $-99M.
Tekla Capital Management has $2.6B in assets under management (AUM), dropping by -2.71%.
Central Index Key (CIK): 0001300336

Tip: Access up to 7 years of quarterly data

Positions held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Tekla Capital Management

Tekla Capital Management holds 166 positions in its portfolio as reported in the June 2023 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Amgen Common (AMGN)	5.4	$137M	+10%	617k	222.02	View chart
Johnson & Johnson Common (JNJ)	4.7	$120M		722k	165.52	View chart
Gilead Sciences Common (GILD)	4.6	$118M		1.5M	77.07	View chart
Regeneron Pharmaceuticals Common (REGN)	4.5	$116M	+12%	161k	718.54	View chart
Vertex Pharmaceuticals Common (VRTX)	4.4	$112M	-3%	318k	351.91	View chart
Eli Lilly and Company Common (LLY)	3.9	$100M	-26%	213k	468.98	View chart
Unitedhealth Group Common (UNH)	3.9	$100M	-11%	207k	480.64	View chart
Merck & Co Common (MRK)	3.3	$84M	+31%	728k	115.39	View chart
AbbVie Common (ABBV)	2.9	$74M	+6%	546k	134.73	View chart
Biogen Common (BIIB)	2.8	$71M	+2%	248k	284.85	View chart
AstraZeneca Sponsored ADR (AZN)	2.7	$70M		977k	71.57	View chart
Illumina Common (ILMN)	2.5	$63M	-3%	337k	187.49	View chart
Abbott Laboratories Common (ABT)	2.4	$60M	-11%	553k	109.02	View chart
Pfizer Common (PFE)	2.3	$60M	-8%	1.6M	36.68	View chart
Thermo Fisher Scientific Common (TMO)	2.0	$52M	+5%	99k	521.75	View chart
Elevance Health Common (ELV)	2.0	$51M		114k	444.29	View chart
Moderna Common (MRNA)	1.6	$42M	+6%	344k	121.50	View chart
Boston Scientific Corp. Common (BSX)	1.4	$36M	+16%	658k	54.09	View chart
Danaher Corp. Common (DHR)	1.3	$34M	+35%	143k	240.00	View chart
Medtronic Shares (MDT)	1.2	$30M		344k	88.10	View chart
IDEXX Laboratories Common (IDXX)	1.2	$29M		59k	502.23	View chart
Dexcom Common (DXCM)	1.2	$29M		229k	128.51	View chart
Bristol-Myers Squibb Company Common (BMY)	1.1	$29M	-30%	459k	63.95	View chart
Intuitive Surgical Common (ISRG)	1.1	$29M	-25%	84k	341.94	View chart
Alnylam Pharmaceuticals Common (ALNY)	1.1	$27M		143k	189.94	View chart
Cigna Group Common (CI)	1.1	$27M	-47%	96k	280.60	View chart
McKesson Corp. Common (MCK)	1.0	$27M	-6%	62k	427.31	View chart
argenx SE Sponsored ADR (ARGX)	1.0	$26M	-25%	66k	389.73	View chart
HCA Healthcare Common (HCA)	1.0	$25M	-7%	82k	303.48	View chart
Stryker Corp. Common (SYK)	1.0	$25M	+13%	81k	305.09	View chart
IQVIA Holdings Common (IQV)	1.0	$25M	+72%	109k	224.77	View chart
Zoetis Class A (ZTS)	0.9	$24M		137k	172.21	View chart
Charles River Laboratories International Common (CRL)	0.9	$23M	-5%	111k	210.25	View chart
Seagen Common	0.8	$22M	-50%	112k	192.46	View chart
Sarepta Therapeutics Common (SRPT)	0.8	$21M	-37%	179k	114.52	View chart
Novo Nordisk A/S Sponsored ADR (NVO)	0.8	$20M	+10%	123k	161.83	View chart
Oculis Holding Common	0.7	$19M		1.7M	11.13	View chart
Molina Healthcare Common (MOH)	0.7	$19M		62k	301.24	View chart
Jazz Pharmaceuticals Shares (JAZZ)	0.7	$18M		148k	123.97	View chart
BioMarin Pharmaceutical Common (BMRN)	0.7	$18M	-29%	211k	86.68	View chart
Edwards Lifesciences Corp. Common (EW)	0.7	$18M	+10%	190k	94.33	View chart
Humana Common (HUM)	0.6	$17M		37k	447.13	View chart
Apellis Pharmaceuticals Common (APLS)	0.6	$16M	+28%	173k	91.10	View chart
Baxter International Common (BAX)	0.6	$15M	+381%	324k	45.56	View chart
Exelixis Common (EXEL)	0.5	$14M		727k	19.11	View chart
Novartis Sponsored ADR (NVS)	0.5	$14M		136k	100.91	View chart
Karuna Therapeutics Common	0.5	$13M	+9%	59k	216.85	View chart
Insulet Corp. Common (PODD)	0.5	$13M	NEW	44k	288.34	View chart
Guardant Health Common (GH)	0.5	$12M	-26%	346k	35.80	View chart
Ascendis Pharma A/S Sponsored ADR (ASND)	0.5	$12M	+12%	139k	89.25	View chart
SPDR S&P Biotech ETF S&P Biotech ETF (XBI)	0.5	$12M		148k	83.20	View chart
Physicians Realty Trust Common	0.5	$12M		874k	13.99	View chart
Tenet Healthcare Corp. Common (THC)	0.5	$12M	NEW	149k	81.38	View chart
BioNTech SE Sponsored ADS (BNTX)	0.4	$11M		104k	107.93	View chart
Neurocrine Biosciences Common (NBIX)	0.4	$11M		113k	94.30	View chart
Zimmer Biomet Holdings Common (ZBH)	0.4	$9.8M		67k	145.60	View chart
Rallybio Corporation Common (RLYB)	0.4	$9.8M		1.7M	5.66	View chart
Vaxcyte Common (PCVX)	0.4	$9.7M	+3784%	194k	49.94	View chart
Alkermes Shares (ALKS)	0.4	$9.7M		310k	31.30	View chart
Denali Therapeutics Common (DNLI)	0.4	$9.6M		325k	29.51	View chart
Avantor Common (AVTR)	0.4	$9.4M		460k	20.54	View chart
Omega Healthcare Investors Common (OHI)	0.4	$9.4M		306k	30.69	View chart
United Therapeutics Corp. Common (UTHR)	0.4	$9.2M	-32%	42k	220.75	View chart
Intra-Cellular Therapies Common (ITCI)	0.3	$8.3M	-23%	131k	63.32	View chart
Acadia Healthcare Company Common (ACHC)	0.3	$8.0M	-45%	101k	79.64	View chart
Madrigal Pharmaceuticals Common (MDGL)	0.3	$8.0M	+175%	34k	231.00	View chart
ResMed Common (RMD)	0.3	$7.6M	-52%	35k	218.50	View chart
Horizon Therapeutics Common	0.3	$7.4M	NEW	72k	102.85	View chart
Inspire Medical Systems Common (INSP)	0.3	$7.1M	NEW	22k	324.64	View chart
Cytokinetics Common (CYTK)	0.3	$7.1M		219k	32.62	View chart
Steris Shares (STE)	0.3	$7.0M		31k	224.98	View chart
Sanofi Sponsored ADR (SNY)	0.3	$6.7M		124k	53.90	View chart
R1 RCM Common (RCM)	0.3	$6.6M		357k	18.45	View chart
CVS Health Corp. Common (CVS)	0.3	$6.5M		94k	69.13	View chart
Medpace Holdings Common (MEDP)	0.3	$6.5M	+185%	27k	240.17	View chart
Immunovant Common (IMVT)	0.2	$6.4M	+191%	336k	18.97	View chart
Intellia Therapeutics Common (NTLA)	0.2	$6.3M		154k	40.78	View chart
LTC Properties Common (LTC)	0.2	$6.0M		182k	33.02	View chart
Sabra Health Care REIT Common (SBRA)	0.2	$6.0M		511k	11.77	View chart
Smith & Nephew Sponsored ADR (SNN)	0.2	$5.9M		182k	32.25	View chart
Chinook Therapeutics Common	0.2	$5.8M	+80%	151k	38.42	View chart
West Pharmaceutical Services Common (WST)	0.2	$5.8M		15k	382.47	View chart
Cerevel Therapeutics Holdings Common (CERE)	0.2	$5.6M		177k	31.79	View chart
LivaNova Common (LIVN)	0.2	$5.6M	+69%	109k	51.43	View chart
Veradigm Common (MDRX)	0.2	$5.4M		429k	12.60	View chart
Agilent Technologies Common (A)	0.2	$5.2M		43k	120.25	View chart
Marinus Pharmaceuticals Common (MRNS)	0.2	$4.5M	-10%	411k	10.86	View chart
uniQure Shares (QURE)	0.2	$4.1M	-45%	356k	11.46	View chart
Amerisourcebergen Corp. Common (COR)	0.2	$3.9M		20k	192.43	View chart
Medical Properties Trust Common (MPW)	0.1	$3.8M		412k	9.26	View chart
BeiGene Sponsored ADR (BGNE)	0.1	$3.7M		21k	178.30	View chart
Ionis Pharmaceuticals Common (IONS)	0.1	$3.6M		88k	41.03	View chart
BioCryst Pharmaceuticals Common (BCRX)	0.1	$3.6M		505k	7.04	View chart
Reata Pharmaceuticals, Inc. Class A Class A	0.1	$3.5M	+91%	34k	101.96	View chart
Teva Pharmaceutical Industries Sponsored ADR (TEVA)	0.1	$3.5M		460k	7.53	View chart
Welltower Common (WELL)	0.1	$3.4M		42k	80.89	View chart
Healthcare Realty Trust Common (HR)	0.1	$3.3M		175k	18.86	View chart
Ventas Common (VTR)	0.1	$3.2M		67k	47.27	View chart
Ishares Biothechnology ETF Common (IBB)	0.1	$3.1M		25k	126.96	View chart
Healthpeak Properties Common (DOC)	0.1	$3.0M		150k	20.10	View chart
Akero Therapeutics Common (AKRO)	0.1	$2.9M	NEW	62k	46.69	View chart
Adaptive Biotechnologies Corp. Common (ADPT)	0.1	$2.8M		422k	6.71	View chart
Galera Therapeutics Common (GRTX)	0.1	$2.8M		898k	3.12	View chart
Xenon Pharmaceuticals Common (XENE)	0.1	$2.6M	-19%	68k	38.50	View chart
Bridgebio Pharma Common (BBIO)	0.1	$2.6M		151k	17.20	View chart
Koninklijke Philips NY Reg Shares (PHG)	0.1	$2.5M	+4%	115k	21.69	View chart
Caribou Biosciences Common (CRBU)	0.1	$2.4M		567k	4.25	View chart
Mirati Therapeutics Common	0.1	$2.4M		66k	36.13	View chart
Icon Shares (ICLR)	0.1	$2.3M		9.3k	250.20	View chart
Amylyx Pharmaceuticals Common (AMLX)	0.1	$2.2M	NEW	104k	21.57	View chart
Assertio Holdings Common (ASRT)	0.1	$2.2M		411k	5.42	View chart
Mereo BioPharma Group Ads (MREO)	0.1	$2.0M		1.6M	1.32	View chart
89bio Common (ETNB)	0.1	$2.0M		106k	18.95	View chart
Ardelyx Common (ARDX)	0.1	$1.8M		539k	3.39	View chart
Pyxis Oncology Common (PYXS)	0.1	$1.8M		708k	2.56	View chart
Perrigo Company Shares (PRGO)	0.1	$1.7M		51k	33.95	View chart
Takeda Pharmaceutical Company Sponsored ADS (TAK)	0.1	$1.7M		105k	15.71	View chart
Global Medical REIT Common (GMRE)	0.1	$1.6M		175k	9.13	View chart
GSK Sponsored ADR (GSK)	0.1	$1.5M		42k	35.64	View chart
Tactile Systems Technology Common (TCMD)	0.1	$1.5M	+69%	59k	24.93	View chart
Arcutis Biotherapeutics Common (ARQT)	0.1	$1.4M		149k	9.53	View chart
Xencor Common (XNCR)	0.1	$1.4M	NEW	57k	24.97	View chart
Crinetics Pharmaceuticals Common (CRNX)	0.1	$1.4M		79k	18.02	View chart
MorphoSys Sponsored ADS (MOR)	0.1	$1.3M	+116%	177k	7.47	View chart
CRISPR Therapeutics Namen AKT (CRSP)	0.0	$1.3M	-59%	23k	56.14	View chart
Natera Common (NTRA)	0.0	$1.2M	-50%	25k	48.66	View chart
Edgewise Therapeutics Common (EWTX)	0.0	$1.2M	-22%	150k	7.75	View chart
Zentalis Pharmaceuticals Common (ZNTL)	0.0	$1.1M	NEW	40k	28.21	View chart
Bicycle Therapeutics Sponsored ADS (BCYC)	0.0	$1.1M	-50%	44k	25.52	View chart
G1 Therapeutics Common	0.0	$1.1M		424k	2.49	View chart
Fulcrum Therapeutics Common (FULC)	0.0	$848k	+338%	257k	3.30	View chart
Scholar Rock Holding Corp. Common (SRRK)	0.0	$821k		109k	7.54	View chart
Diversified Healthcare Trust Common (DHC)	0.0	$805k		358k	2.25	View chart
Theseus Pharmaceuticals Common	0.0	$700k		75k	9.33	View chart
Arcus Biosciences Common (RCUS)	0.0	$667k		33k	20.31	View chart
Black Diamond Therapeutics Common (BDTX)	0.0	$667k		132k	5.05	View chart
iTeos Therapeutics Common (ITOS)	0.0	$606k		46k	13.24	View chart
Intercept Pharmaceuticals Common	0.0	$576k		52k	11.06	View chart
Universal Health Realty Income Trust Common (UHT)	0.0	$536k		11k	47.58	View chart
National Health Investors Common (NHI)	0.0	$526k		10k	52.42	View chart
Beam Therapeutics Common (BEAM)	0.0	$505k		16k	31.93	View chart
TScan Therapeutics Common (TCRX)	0.0	$500k		200k	2.50	View chart
ALX Oncology Holdings Common (ALXO)	0.0	$497k		66k	7.51	View chart
Community Healthcare Trust Common (CHCT)	0.0	$492k		15k	33.02	View chart
I-Mab Sponsored ADS (IMAB)	0.0	$486k		163k	2.99	View chart
Novavax Common (NVAX)	0.0	$474k		64k	7.43	View chart
HilleVax Common (HLVX)	0.0	$464k	NEW	27k	17.19	View chart
Sutro Biopharma Common (STRO)	0.0	$457k		98k	4.65	View chart
Community Health Systems Common (CYH)	0.0	$389k		88k	4.40	View chart
Affimed Common	0.0	$351k		586k	0.60	View chart
Repare Therapeutics Common (RPTX)	0.0	$308k		29k	10.58	View chart
Altimmune Common (ALT)	0.0	$265k		75k	3.53	View chart
Fusion Pharmaceuticals Common	0.0	$203k		43k	4.68	View chart
Codexis Common (CDXS)	0.0	$194k		69k	2.80	View chart
Harpoon Therapeutics Common	0.0	$185k		260k	0.71	View chart
Precision BioSciences Common	0.0	$118k		225k	0.53	View chart
Spectrum Pharmaceuticals Common	0.0	$110k		115k	0.96	View chart
Adicet Bio Common (ACET)	0.0	$98k		40k	2.43	View chart
Praxis Precision Medicines Common	0.0	$86k		75k	1.15	View chart
ARCA biopharma Common (ABIO)	0.0	$66k		33k	2.03	View chart
Nkarta Common (NKTX)	0.0	$64k		29k	2.19	View chart
Mallinckrodt Shares	0.0	$41k		35k	1.18	View chart
Corbus Pharmaceuticals Holdings Common (CRBP)	0.0	$40k		5.1k	7.84	View chart
VYNE Therapeutics Common (VYNE)	0.0	$31k		7.5k	4.06	View chart
NexGel Common (NXGL)	0.0	$11k		4.2k	2.51	View chart
Bellicum Pharmaceuticals Common	0.0	$2.2k		6.0k	0.37	View chart

Past Filings by Tekla Capital Management

SEC 13F filings are viewable for Tekla Capital Management going back to 2010

Tekla Capital Management 2023 Q2 filed Aug. 10, 2023
Tekla Capital Management 2023 Q1 filed May 10, 2023
Tekla Capital Management 2022 Q4 filed Feb. 10, 2023
Tekla Capital Management 2022 Q3 filed Nov. 1, 2022
Tekla Capital Management 2022 Q2 filed July 29, 2022
Tekla Capital Management 2022 Q1 filed May 13, 2022
Tekla Capital Management 2021 Q4 filed Feb. 14, 2022
Tekla Capital Management 2021 Q3 filed Nov. 12, 2021
Tekla Capital Management 2021 Q2 filed Aug. 13, 2021
Tekla Capital Management 2021 Q1 filed May 14, 2021
Tekla Capital Management 2020 Q4 filed Feb. 12, 2021
Tekla Capital Management 2020 Q3 filed Nov. 13, 2020
Tekla Capital Management 2020 Q2 filed Aug. 13, 2020
Tekla Capital Management 2020 Q1 filed May 14, 2020
Tekla Capital Management 2019 Q4 filed Feb. 13, 2020
Tekla Capital Management 2019 Q3 filed Nov. 13, 2019

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z